EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine Models

Makoto Taniguchi iD, Toshiro Okazaki iD

Journal of Lipid and Atherosclerosis · 2020 · 9 (3) · 380

DOI: 10.12997/jla.2020.9.3.380 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Lipid and Atherosclerosis, 2020. Verfasst von Makoto Taniguchi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Medical Research Institute, Kanazawa Medical University, Kahoku, Japan. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS KAKENHI, Takeda Science Foundation, Shalome Co. Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ceramide and sphingomyelin (SM) are major components of the double membrane-bound sphingolipids. Ceramide is an essential bioactive lipid involved in numerous cell processes including apoptosis, necrosis, and autophagy-dependent cell death. Inversely, SM regulates opposite cellular processes such as proliferation and migration by changing receptor-mediated signal transduction in the lipid microdomain. SM is generated through a transfer of phosphocholine from phosphatidylcholine to ceramide by SM synthases (SMSs). Research during the past several decades has revealed that the ceramide/SM balance in cellular membranes regulated by SMSs is important to decide the cell fate, survival, and proliferation. In addition, recent experimental studies utilizing SMS knockout mice and murine disease models provide evidence that SMS-regulated ceramide/SM balance is involved in human diseases. Here, we review the basic structural and functional characteristics of SMSs and focus on their cellular functions through the regulation of ceramide/SM balance in membrane microdomains. In addition, we present the pathological or physiological implications of SMSs by analyzing their role in SMS-knockout mice and human disease models. This review finally presents evidence indicating that the regulation of ceramide/SM balance through SMS could be a therapeutic target for human disorders.

Schlagwörter

Stichwörter der Autor:innen

Ceramide/SM balanceCeramidesMurine disease modelsSMSSphingomyelins

Autor:innen und Institutionen

  • Department of Life Science, Medical Research Institute, Kanazawa Medical University, Kahoku, Japan.
  • Research Institute for Bioresources and Biotechnology, Kanazawa Prefectural University, Nonoichi, Japan.

ORCID-Profile: Makoto Taniguchi, Toshiro Okazaki

Förderung

  • JSPS KAKENHI
  • Takeda Science Foundation
  • Shalome Co. Ltd.
  • Strategic Research Foundation Grant-aided Project for Private Universities from the MEXT

Zitieren

APA

Taniguchi, M., & Okazaki, T. (2020). Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine Models. Journal of Lipid and Atherosclerosis, 9(3), 380. https://doi.org/10.12997/jla.2020.9.3.380

Vancouver

Taniguchi M, Okazaki T. Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine Models. Journal of Lipid and Atherosclerosis. 2020;9(3):380. doi:10.12997/jla.2020.9.3.380

BibTeX
@article{Taniguchi2020,
  author = {Taniguchi, Makoto and Okazaki, Toshiro},
  title = {Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine Models},
  journal = {Journal of Lipid and Atherosclerosis},
  year = {2020},
  volume = {9},
  number = {3},
  pages = {380},
  doi = {10.12997/jla.2020.9.3.380}
}
Kostenlos starten →